Skip to main content
. 2023 Dec 11;10:1298743. doi: 10.3389/fnut.2023.1298743

Table 5.

Schedule of measurements for index participants.

Study period timepoints
Eligibility Enrolment Intervention and follow up
Visit 1
Screening
Visit 2
Baseline Enrolment
Phone contact Email Contact Visit 3a
Control only
Visit 3b Visit 4 Visit 5
RCT1 control group Week 0 Week 12 Week 24 Week 36 Week 64
RCT1 intervention group Week 2 Week 6 Week 12 Week 24 Week 52
Eligibility screen
Informed consent
Medical history
Education about RCT 1 and RCT 2
Questionnaires
Otago short-form FFQ
24 h dietary recall
IPAQ Physical activity
Kaupapa Māori Wellbeing questionnaire
Three factor eating questionnaire
Gastrointestinal symptom rating scale
Self-Evaluation COM questionnaire
Impact evaluation for nutrition and behavior change support
SF-36 quality of life
Assessments
Height
Clinical measurementsa
Body composition
Current medications
Adverse events
Fasting blood samples b
Fecal sample

aWeight, waist circumference, height, blood pressure in triplicate. bHbA1c, fasting glucose, lipids and metabolites and hormones related to metabolic health Household/whanau members will attend visits 2, 3a/3b, 4, and 5.